Welcome to The Briefing: Register or log in to tailor our content to your needs

The Briefing is all about showing you what you're most interested in. Personalize the content on The Briefing by choosing exactly what you want to see.

Subject Relevance


In-Vitro Diagnostics

1 - 10 of 503 items

Scientists develop single molecule electrical sensing mechanism to detect disease, including Ebola

Sensors that are able to gauge the electrical properties of single molecules may turn out to be excellent diagnostic devices able to spot microbes and biomarkers of disease. Turns out that there’s been a barrier to making such devices because simply… Read more →

A new test for Ovarian cancer detection found

A new test can help doctors identify ovarian cancer more accurately and cut down on instances of unnecessary surgery, claim scientists.

It is designed to help diagnose different types and stages of ovarian cancer.

The developers, in Belgium… Read more →

Clinical study of Proxima miniature in-line blood gas analyser meets primary end point

Sphere Medical, innovator in critical care monitoring and diagnostics equipment, is pleased to announce the completion of a successful clinical study of its new Proxima miniature in-line blood gas analyser at the Queen Elizabeth Hospital, Birmingham, UK. The observational method… Read more →

Novel ‘designer’ nanodevice could improve cancer diagnostics, treatment

Cancer diagnostics and treatment options could be drastically improved with the creation of a ‘designer’ nanodevice being developed by researchers from the UK, Italy, the US and Argentina.

The diagnostic ‘nanodecoder’, which will consist of self-assembled DNA and protein nanostructures,… Read more →

Philips Digital Pathology Solution receives CE Mark for diagnosis to help advance oncology diagnosis

Royal Philips (NYSE: PHG, AEX: PHIA) has acquired the CE mark for diagnostic use of its Philips Digital Pathology Solution. European pathologists will now be able to use the full digital solution as an aid in diagnosis for routine pathology,… Read more →

CSL Plasma chooses OrSense’s NBM200 Hb testing device for screening Hb levels in plasma donors

OrSense Ltd., developer of solutions for non-invasive measurements of hemoglobin, today announced that CSL Plasma, Germany, has completed the transition to OrSense’s NBM200 Hb testing device for screening of Hb levels in plasma donors.

CSL Plasma is one of the… Read more →

Primerdesign develops simple diagnostic test solution to contain 2014 Ebola outbreak

High-tech British company Primerdesign Ltd, a spin-off company from the University of Southampton, has developed a fast and simple diagnostic test solution specific to the 2014 Ebola outbreak.

With the current epidemic of Ebola virus in West Africa, Primerdesign are… Read more →


RNA Molecules in Urine and Tissue Can Detect Prostate Cancer

Researchers at Sanford-Burnham Medical Research Institute have identified a set of RNA molecules that are detectable in tissue samples and urine of prostate cancer patients, but not in normal healthy individuals. The study sets the stage for the development of… Read more →

Molecular diagnostics and blood screening systems: an interview with Dr Bos and Dr Koppelman

How have the needs of molecular diagnostics laboratories evolved over time?

Screening blood donations and molecular diagnostics for patients started in the nineties. At the beginning, the level of automation in molecular diagnostic testing was limited; most of the work… Read more →

NCI awards $1.4M grant to Advanced Cell Diagnostics to develop diagnostic test for B-cell NHLs

Advanced Cell Diagnostics, Inc. (ACD), a global technology and market leader in in situ nucleic acid detection for life science research and clinical diagnostics, has been awarded a two-year, $1.4 million grant from National Cancer Institute (NCI) under its SBIR… Read more →

Cookies on IBME website

Our website uses cookies to provide us with important information about visitors. By continuing to browse the site we'll assume that you are happy to receive all cookies set by IBME.